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In his introduction to the two volumes of Gene Therapy Protocols,
from the prestigious Methods in Molecular Biology series, Joseph
M Le Doux reminds us that the idea behind gene therapy is
deceivingly simple: ‘to deliver genetic material to cells that will
slow down or halt the progression of disease, or to help repair or
degenerate damaged or lost tissues’.
One may add that although traditional drugs act by direct and
transient modification of a biological target, the original proposal
of gene therapy is to reprogramme the cells. The idea must have
been around in the minds of many a postmodern Jules Verne, ever
since Avery, Mc Leod and Mc Carthy showed in 1944 that the
phenotype of bacteria could be modified by DNA transfer. Yet,
major scientific breakthroughs, including recombinant DNA, had
to take place before gene isolation, modification and transfer
became a reality, an indispensable tool for modern biology and a
technology with great potential for medical application.
The simple idea of gene therapy may be applied to the whole of
medicine, from sport-related injuries to neurodegenerative
diseases and cancer. Ever since the first clinical trial in 1989, the
prospect of gene therapy has caused high expectations. Proofs of
concept have accumulated rapidly in animal models of human
diseases, and clinical studies have shown biological responses or
clinical efficacy in human patients with genetic diseases affecting
the immune system, skin or blood clotting. Positive data have also
been reported in patients with AIDS, melanoma and Parkinson’s
disease.
The two volumes of Gene Therapy Protocols are dedicated to the
various aspects of gene transfer technologies. Gene transfer can be
obtained using physical methods, such as electric fields or
ultrasounds, that create a temporary access to the intracellular
milieu for exogenous nucleic acids. It can also be mediated by
vectors that are able to package and deliver genetic information.
Vectors can either be formed by synthetic macromolecules, such as
polycations, cationic lipids or peptides, or by recombinant viral
particles endowed with the sophisticated cell invasion capacities of
the parent virus. Synthetic vectors may offer the advantage of
simpler manufacturing processes and industrial scale-up when
compared with viral vectors that involve complex biotechnological
procedures and cell culture. Yet, the efficacy of viral vectors often
designates them as the only tools available for clinical application.
A total of 40 short chapters constitute the two Gene Therapy
Protocols volumes, somewhat artificially separated into Volume 1:
Production and In Vivo Applications of Gene Transfer Vectors
and ‘Volume 2: Design and Characterization of Gene transfer
Vectors. Each chapter includes a brief introduction and
practical sections designed to be directly usable at the bench as
much as possible. A valuable feature is the note section in which
comments and troubleshooting tips are given, allowing
new cooks to benefit from the experience of renowned chefs.
This pattern is perfect for most chapters describing methods,
but may be less fit for chapters in which applications are
described. Those may have been clearer and lighter with a simple
report format and cross-reference with the methodological
chapters.
Non-viral vectors are qualitatively well represented in the two
volumes, although they represent a minority of chapters. The
contributions on these technologies are of the highest level, with
detailed and thorough protocols. Most chapters (27/40) describe
viral vector-based technologies: gammaretroviruses and lenti-
viruses, adenoviruses (including the more advanced ‘helper-
dependent’ kind), parvoviruses (adeno-associated viruses (AAVs))
and a single chapter for herpesviruses that reflect the marginal
use of this vector family. Among these, authoritative contributions
by leaders in the field can be found, but they are sometimes
diluted by chapters with less informational content. Those
chapters might have been useful for true beginners and students,
but most readers will not need explanations at the level of an
inaccurate high school textbook. For instance: ‘ythe virus delivers
this DNA cassette to the host cell nucleus and the reporter genes
get integrated within the host genome. As the host genome
replicates, the messenger RNA (mRNA) for the reporter gene
combination also replicates (sic). Then the mRNA molecules are
translated to proteins within the cytoplasm’ (legend to figure 1 in
volume 1, page 180).
Another editorial weakness is that most chapters contain their
own variation of a vector preparation protocol, with, for instance,
eight different protocols for g-retroviral vector preparation. The
reader is, therefore, faced with the difficulty of choosing for
reference. In addition, beginners in the field may be left with the
idea that the success of the application methods is associated with
slight variations (if not black magic) in the production method.
Instilling this notion may be dangerous and may work against the
goal of having standardised, quantifiable and comparable methods
in the field.
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representation of the field 5 years ago. The latest developments and
diversity of lentiviral and AAV vectors do not appear. This is
obviously a common problem of this kind of book that tries to
bring a broad coverage of a fast evolving technology. In this
respect, a well-maintained web version of Gene Therapy Protocols
would be highly useful to a scientific community who now usually
refer to this media when searching for a protocol. An online
version could allow access to the illustrations of the book, which
are generally of a high quality and which would certainly be
appreciated by the readership.
These two volumes give a good overview of the busy field of
gene transfer vector research. Putting together in a clear format
such a variety of approaches and expertises is not a small feat, and
the benefit of the enterprise is not diminished by the unavoidable
editorial imperfections. The result is the two volumes that will
certainly not stay idle on the library shelf.
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